| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.03 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.03 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.03 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.09 | 0.03 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.12 | 0.03 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.075 | 0.03 |